ganoderic acid A

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2012-2017
02420122017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Ganoderic acid A (GAA), a representative active triterpenoid from Ganoderma lucidum, has been reported to exhibit antinociceptive… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Ganoderic acid A (GA‑A), a triterpenoid, has been demonstrated to suppress cell proliferation in various cancers, including… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Ganoderic acid A (GAA), an active triterpenoid of the traditional Chinese herbal medicine Lingzhi, has been reported to exhibit… (More)
Is this relevant?
2017
2017
Twenty isolates of Ganoderma spp. indigenous to India were used in this study. A reverse-phase high-performance liquid… (More)
Is this relevant?
2017
2017
Due to the highly specific binding between an antibody and its target, superior analytical performances was obtained by… (More)
Is this relevant?
2016
2016
Evaluating anti-oxidant potential of Ganoderic acid A in STAT 3 pathway in Prostate cancer. Molecular docking and ADMET… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 3
Is this relevant?
2016
2016
Ganoderic acid A (GAA) is one of the major Ganoderma triterpenes produced by medicinal mushroom belonging to the genus Ganoderma… (More)
Is this relevant?
2016
2016
Ganoderma is a genus of medicinal mushroom traditionally used for treating various diseases. Ganoderic acid A is one of the major… (More)
Is this relevant?
2015
2015
Ultra-performance liquid chromatography (UPLC) and Single Standard for Determination of Multi-Components (SSDMC) are becoming… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2012
2012
Ganoderic acid A is a lanostane triterpene isolated from Ganoderma lucidum. It has been reported to exhibit antitumor activity… (More)
Is this relevant?